P437 |
Estrogen
receptor alpha and beta (ERa and -b) gene and protein expression
in breast cancer cell lines: verification by RT-PCR and Western
blotting |
|
MD Al-Bader, CHJ Ford, J Jacob, LJ Jacob & SS
Mohan |
P438 |
Challenges
associated with the diagnosis, differential diagnosis and treatment
of 4 cases of ACTH-dependent Cushing's syndrome due to intermittent
hypercortisolism |
|
JR Lindsay & LK Nieman |
P439 |
Hyperprolactinaemia
in a series of adults with craniopharyngiomas and Rathke's cleft
cysts: what are the upper limits? |
|
G Thanabalasingham, N Karavitaki, N Meston,
HE Turner & JAH Wass |
P440 |
Parathyroid
scintigraphy for hyperparathyroidism, an assessment of performance |
|
T Vizhalil Paul, N Thomas, M Seshadri, S
Rajaratinam, K Sudeep & J Jubbin Jagan |
P441 |
Insulinomas
- an experience from a tertiary care institution in South India |
|
T Vizhalil Paul, N Thomas, M Seshadri, K
Senthilvasan, E Esther & K Sudeep |
P442 |
Biological
diagnosis of 63 pheochromocytomas and/or paragangliomas |
|
M d'Herbomez, C Bauters, N Rouaix, G Forzy,
C Do Cao, B Carnaille & JL Wemeau |
P443 |
Dedifferentiated
papillary thyroid cancer. Use of array CGH in searching for prognostic
markers |
|
A Gazdag, G Pocsay, R Pocsay, L Puskas, L
Feher, E Tarko & M Tarko |
P444 |
Stereotactic
conformal radiotherapy in pituitary adenomas - outcome in 36 consecutive
patients during years 1996-2004 |
|
C Schalin-Jäntti, L Valanne, M Kouri & T
Sane |
P445 |
Intra-ovarian
adrenocortical carcinoma |
|
F Chentli, F Yesli, N Meziani, S Alem, N
Kesri & S Fedala |
P446 |
Comparative
efficacy of therapy by sandostatin and parlodel of patients with
acromegalia |
|
ZY Khaimova & AA Khalikova |
P447 |
Pituitary
tumors in Republic of Croatia |
|
M Vrkljan, A Maric, M Matovinovic, V Cerina,
D Herman & HI Pecina |
P448 |
Histological
pecularities of pituitary adenomas |
|
ZY Khalimova & ER Magdieva |
P449 |
Surgical
treatment in acromegaly: predictors of outcome |
|
PV Iushkov, NN Molitvoslovova, EG Luljeva & EI
Marova |
P450 |
Pituitary
mass and hypothyroidism. A case report |
|
H Smida, R Bouguerra, L Ben Salem, N Younsi,
CH Saidi & C Ben Slama |
P451 |
Incidence
rate of thyroid cancer in Olsztyn region in the years 1993-2004 |
|
E Bandurska-Stankiewicz & E Aksamit-Białoszewska |
P452 |
A
typical clinical picture of four insulinoma cases |
|
M Kurowska, J Malicka, JS Tarach & A
Nowakowski |
P453 |
What
is the best glycaemic index for diagnosis of insulinoma? |
|
JM Andrieu, DB Bassiri, RM Ramdani, EG Guzman,
JF Fabre, EA Aboud & JC Courreges |
P454 |
Sustained
correction of hypercortisolism with a low dose mitotane regimen
in a young woman with PPNAD and Carney Complex |
|
M Campo, G Picca, ED Laudadio, O Lamacchia & M
Cignarelli |
P455 |
Hypocorticism
after radiosurgery (protonotherapy) in patients with normal MRI
and in patients with confirmed tumor for Cushing's disease |
|
OV Manchenko & EI Marova |
P456 |
Prognostic
value of Ki-67 expression in the cytologic identification of pancreatic
endocrine tumors: preliminary data |
|
MF Manzoni, GM Franchi, C Piani, C Cappelletti,
PG Arcidiacono, L Albarello, C Doglioni & E Bosi |
P457 |
Difficulties
in diagnosing persistent acromegaly using current consensus criteria
for cure after transsphenoidal surgery |
|
M Petakov, M Djurovic, S Ognjanovic, DJ Macut,
T Isailovic, B Popovic, I Bozic, M Joksimovic & S Damjanovic |
P458 |
Carbohydrate
metabolism in patients with hypercorticism |
|
V Chachibaia, M Korinteli, E Giorgadze, B
Gvadzabia & K Bochorishvili |
P459 |
Role
of family history for diabetes mellitus in determining insulin
resistance in acromegalic patients |
|
F Diacono, D Pietrobono, G Bassotti, L Borgognoni,
D Di Sarra, R Iuorio, P Gargiulo & G Tamburrano |
P460 |
Familial
acromegaly |
|
G Oruk, O Kucuksahin, D Soysal, E Tatar & C
Ozdemir |
P461 |
Role
of complex Cdk4/cyclin D1 in somatostatin subtype 2 receptor-mediated
inhibition of cell proliferation of a medullary thyroid carcinoma
cell line |
|
in vitro F Tagliati, MC Zatelli, A Bottoni,
D Piccin, A Luchin, MD Culler & EC degli Uberti |
P462 |
Selective
cyclo-oxygenase 2 inhibitors revert chemoresistance in medullary
thyroid carcinoma by a mechanism mediated by P-gp and PGH2 |
|
MC Zatelli, A Luchin, D Piccin, F Tagliati,
A Bottoni, C Vignali, M Bondanelli & EC degli Uberti |
P463 |
An
intrasellar germinoma with normal cerebrospinal fluid b-HCG concentration
misdiagnosed as hypophysitis |
|
S Tanyolac, A Cikim, N Ozbey, A Sencer, R
Kurt, S Sencer, I Turantan & S Molvalilar |
P464 |
Response
to medical treatment in male macroprolactinomas |
|
F Chentli, S Azzoug & S Boudiar |
P465 |
Non-functioning
pituitary tumors |
|
F Chentli, N Meziani, K Takbou, C Habbak,
S Bendaoud, L Cherf & AEM Haddam |
P466 |
Diabetic
retinopathy in acromegaly |
|
S Azzoug, A Adem & F Chentli |
P467 |
Malignant
catecholamine-secreting paragangliomas of retrocardial localization |
|
M Sabljar-Matovinovic, I Prkacin, N Crkvencic,
S Gracin & M Knotek |
P468 |
Short-term
evaluation of quality of life in acromegalic patients |
|
C Sardella, C Cosci, S Gavioli, F Bogazzi & E
Martino |
P469 |
Octreotide
as alternative to surgical adrenalectomy |
|
D Katalinic, G Mirosevic & V Zjacic-Rotkvic |
P470 |
Inhibition
of IGF-II signal transduction improves chemosensitivity in human
adrenocortical cancer cells |
|
S Hahner, E Beidinger, A Stuermer, AC Koschker,
D Weismann, M Fassnacht & B Allolio |
P471 |
The
new TNM classification is inferior to the Lee classification in
predicting outcome in patients with adrenocortical carcinoma |
|
M Fassnacht, AC Koschker, S Hahner, U Maeder,
D Weismann, T Linden, M Quinckler, H Willenberg, P Bucsky, S Diehl,
M Brauckhoff, M Schaefer, N Schlenz, K Muessig, M Reincke & B
Allolio |
P472 |
Stimulated
and spontaneous growth hormone release in irradiated acromegalic
patients |
|
AA van der Klaauw, AM Pereira, SW van Thiel,
JWA Smit, EPM Corssmit, NR Biermasz, M Frohlich, A Iranmanesh,
JD Veldhuis, F Roelfsema & JA Romijn |
P473 |
WNT4
expression in normal human adrenals and adrenocortical tumours |
|
T Kuulasmaa, J Jääskeläinen,
T Pietiläinen, S Loimas, S Aaltomaa, P Heikkilä, V-M
Kosma & R Voutilainen |
P474 |
The
clinical particularities, medical possibility of prolactinomas
in men |
|
LK Dzeranova, VV Vax & EN Giniatullina |
P475 |
Management
of thyroid cancer in children |
|
A Mazilu, AE Ranetti, A Mihai & C Spiroiu |
P476 |
Diagnosis
difficulties in insulinomas |
|
AE Ranetti, A Mazilu, C Spiroiu & A Mihai |
P477 |
Insulin-like
growth factor-I signalling in tamoxifen sensitive and tamoxifen
resistant breast cancer cells |
|
CJ McVittie, S Khalaf, W Ogunkolade, R Carpenter,
SA Bustin & PJ Jenkins |
P478 |
Functioning
adrenocortical carcinoma and the clinical endocrinologist: toxic
treatments and poor prognosis |
|
RM Thomas, R Bliss, D Richardson, S Johnson,
S Turner, S Bennett & R Quinton |
P479 |
Post-operative
serum cortisol for prediction of long-term remission from Cushing's
syndrome |
|
JR Lindsay, EH Oldfield & LK Nieman |
P480 |
An
in-frame complex germline mutation in the juxtamembrane intracellular
domain causing RET activation in familial medullary thyroid carcinoma |
|
L Fugazzola, D Cordella, M Muzza, L Alberti,
P Travaglini, P Colombo, P Beck-Peccoz & L Persani |
P481 |
Macroprolactinoma:
5 cases |
|
I Hadj Ali, H Cheikhrouhou, K Khiari & N
Ben Abdallah |
P482 |
48h
appears as sufficient duration of fasting in the diagnosis of insulinoma
- a single centre experience with 23 cases |
|
M Quinkler, F Strehlow, H Biering, M Pirlich,
H Gerl, CJ Strasburger & M Ventz |
P483 |
A
case of a patient with differentiated thyroid carcinoma and metastases
to the kidneys |
|
Z Adamczewski, J Makarewicz, M Knapska- Kucharska,
L Oszukowska, A Karwowska & A Lewinski |
P484 |
Development
of a non-isotopic immunoassay for the measurement of aldosterone
in saliva |
|
J Manolopoulou & M Bidlingmaier |
P485 |
Thyroid
autoimmunity and breast cancer (BC): absence of morphological autoimmune
changes in breast malignant tissue |
|
EG Giustarini, AP Pinchera, PF Fierabracci,
DC Campani & CG Giani |
P486 |
Pituicytoma
- a case report |
|
P Rao-Balakrishna, C Dang, K Gnanalingam,
H Reid & T Kearney |
P487 |
PTTG
promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid
cancer |
|
DS Kim, MA Buchanan, AL Stratford, R Susarla,
JC Watkinson, MC Eggo, JA Franklyn & CJ McCabe |
P488 |
Multiple
endocrine neoplasia type 1 (MEN 1) is associated with insulin resistance
and an increased prevalence of diabetes and impaired fasting glucose |
|
RW McCallum, V Parameswaran & JR Burgess |
P489 |
Evaluation
of a standardized protocol for the collection and storage of adrenal
tumor samples - preparation for a European adrenal tumor bank (ENS@T) |
|
I Johnsen, S Hahner, M Fassnacht, J Bertherat,
X Bertagna, PF Plouin, M Reincke, B Allolio & F Beuschlein |
P490 |
Value
of overnight dexamethasone suppression test (1mg-DST) in subclinical
Cushing's syndrome |
|
Z Penezic, M Zarkovic, M Ivovic, S Vujovic,
J Ciric, BZ Beleslin, M Stojanovic, LJ Marina & M Drezgic |
P491 |
Effect
of catecholamine uptake inhibition on catecholamine content in
human adrenal chromaffin cells and pheochromocytes |
|
J Rosmaninho-Salgado, AR Álvaro, D
Grand, A Mota, E Grouzmann & C Cavadas |
P492 |
PTTG
binding factor (PBF) can transform cells independently of interaction
with PTTG |
|
AL Stratford, K Boelaert, DS Kim, JA Franklyn & CJ
McCabe |
P493 |
Carney's
complex with acromegaly as the leading clinical condition |
|
LM Fatti, G Bertola, G Balza, E Lavezzi,
F Pecori Giraldi & F Cavagnini |
P494 |
Daily
profiles of aldosterone secretion in primary aldosteronism |
|
J Ciric, M Zarkovic, B Beleslin, Z Penezic,
M Stojkovic, S Savic & B Trbojevic |
P495 |
Analysis
of succinyl dehydrogenase (SDH) subunits gene mutations in patients
with paragangliomas |
|
A Krawczyk, K Hasse-Lazar, A Pawlaczek, D
Rusinek, S Szpak-Ulczok, M Peczkowska, A Preibisz, A Kubaszek,
E Gubala, A Januszewicz & B Jarzab |
P496 |
Neuropeptide
Y-Y1 receptors mediate the effects of neuropeptide Y on prostate
cancer cell growth |
|
M Ruscica, E Dozio, M Motta & P Magni |
P497 |
Differential
expression of neurogenins by human pituitary adenomas |
|
A Fratticci, R Padronetti, F Giangaspero,
L Ventura, M Piccirilli, V Esposito, A Gulino, E Alesse & ML
Jaffrain-Rea |
P498 |
Evidence
for an attenuated 11betahydroxysteroid dehydrogenase type-1 response
to an inflammatory stimulus in primary cultures of epithelial ovarian
cancer |
|
KS Fegan, MT Rae & SG Hillier |
P499 |
Long-term
somatostatin analog octreotide treatment in insulinoma patients |
|
D Vezzosi, A Bennet, F Courbon & P Caron |
P500 |
Development
of dopamine agonist resistance and progression from microadenoma
to macroadenoma in two women with hyperprolactinaemia |
|
D McCall, SJ Hunter, RS Cooke, B Herron,
B Sheridan & AB Atkinson |
P501 |
The
rare RET mutation (insTTCTdelG) at codon 666 is associated with
a low penetrance of medullary thyroid carcinoma and pheochromocytoma |
|
M Bex, B Decallonne, G Matthijs & E Legius |
P502 |
Use
of TRH in addition to CRH stimulation during bilateral petrosal
sinus sampling in Cushing's syndrome - long term experience |
|
P Sathiskumar, J Wright & TA Howlett |
P503 |
Glucagonoma
syndrome - treatment with intensive insulin and high dose vitamin
B complex |
|
NA Phelan, M Shahid, N Correia, T Kyaw Tun,
KC Conlon & J Gibney |
P504 |
Headaches
cured by surgery |
|
A Banerjee, M Balaratnam, W Dhillo, N Mendoza & K
Meeran |
P505 |
Chromogranin-a
in adrenal incidentalomas - marker for tumour secretion |
|
M Ivovic, Z Penezic, S Vujovic, Lj Marina,
M Stojanovic & M Drezgic |
P506 |
A
novel germ-line mutation GLY321ARG in the exon 5 of the RET proto-oncogene
detected in a family with familial medullary thyroid carcinoma |
|
E Vaclavikova, S Dvorakova, J Duskova, P
Vlcek, A Ryska & B Bendlova |
P507 |
Contemporary
management of macroprolactinomas |
|
AI Palalau, C Miller, NJ Gittoes & AA
Toogood |
P508 |
Cushing's
paraneoplastic syndrome secondary to recurrent ovarian carcinoma |
|
J Combes, S Chabroux, D Debieuvre & JP
Ory |
P509 |
Molecular,
genetic and clinical characterisation of neurofibromatosis type
1-associated pheochromocytoma |
|
B Bausch & HP Neumann |
P510 |
AcroBel:
a registry and survey on acromegaly in Belgium |
|
M Bex, R Abs, GT Sjoen, J Mockel, B Velkeniers & D
Maiter |
P511 |
The
latest safety and efficacy data of patients treated with pegvisomant |
|
I Schreiber, K Forssmann, M Buchfelder, M
Droste, K Mann, B Saller & CJ Strasburger |
P512 |
Mutation
at codon 804 in a Greek kindred detected by screening of the six
RET exons in patients with medullary thyroid carcinoma |
|
N Mytakidis, E Vassiliou, V Liakos, L Papagrigoriou,
F Hadzimarkou, I Kostoglou-Athanasiou, G Koutsodontis, A Ladopoulou,
T Bei, D Yannoukakos & P Kaldrymidis |
P513 |
A
rare RET gene mutation is found in two apparently unrelated Greek
kindreds with familial medullary thyroid carcinoma |
|
N Mytakidis, M Zachariou, T Anagnostopoulos,
E Vassiliou, D Thomas, A Tertipi, T Rampias, I Konstantopoulou,
P Natsis, D Yannoukakos & P Kaldrymidis |
P514 |
Surgical
cure with preserved pituitary function is rare in acromegalic patients.
Results from the POTA study (preoperative octreotide treatment
of acromegaly) |
|
SM Carlsen, T Schreiner, S Anderud, Ø Johannesen,
J Svartberg & J Bollerslev |
P515 |
Different
scintigraphic patterns between sympathetic and parasympathetic
paragangliomas |
|
MS Gaglianò, L Simi, T Ercolino, L
Becherini, R Sestini, M Mascalchi, M Genuardi, V Briganti, G La
Cava, C Olianti & M Mannelli |
P516 |
mRNA
expression of somatostatin receptor subtypes in pheochromocytomas/
paragangliomas |
|
M Mannelli, S Gelmini, F Malentacchi, L Simi,
MS Gaglianò, T Ercolino, L Becherini, A Valeri, C Pratesi & C
Orlando |
P517 |
A
retrospective review of the effect of pituitary radiotherapy after
trans-sphenoidal surgery for non-functioning pituitary adenomas |
|
P Chellamuthu, I Robertson, MJ Levy & TA
Howlett |
P518 |
Biochemical
characteristics of 'silent' ACTHsecreting pituitary adenomas: preoperative
serum and urine studies |
|
C Maser-Gluth, G Artlich, A Gutenberg & M
Buchfelder |
P519 |
Radiotherapy
and o,p'-DDD induce an inhibition of growth and interfere in the
cell cycle in H295-R adrenocortical cell line |
|
A Stigliano, L Cerquetti, B Bucci, P Carlini,
D Amendola, S Misiti, R Miceli, U de Paula, E Brunetti & V
Toscano |
P520 |
Role
of PKA regulatory subunit 2B protein on cortisol-secreting adrenocortical
cells proliferation |
|
A Lania, G Mantovani, S Bondioni, E Peverelli,
S Ferrero, L Vicentini, S Bosari, P Beck-Peccoz & A Spada |
P521 |
Outcome
of management of craniopharyngiomas - a contemporary series |
|
JD Rippin, RD Mitchell, EJ McGregor, AA Toogood & NJ
Gittoes |
P522 |
Anatomo-clinical
features in multihormonal prolactinomas |
|
D Voicu, C Badiu, D Hortopan, C Stancu, A
Caragheorgheopol & M Coculescu |
P523 |
Glucocorticoid
receptor gene N363S variant in patients with clinically inapparent
adrenal adenomas |
|
G Reimondo, I Micossi, D Giachino, S Bovio,
B Allasino, F Daffara, A Angeli, M Terzolo & M De Marchi |
P524 |
Characteristics
and follow-up of thyroid cancer in patients with hyperthyroidism |
|
M Boudina, K Pazaitou-Panayiotou, A Chrisoulidou,
A Drimonitis, A Kaprara, E Georgiou & I Vainas |
P525 |
Investigation
and surgical management of pancreatic neuroendocrine tumours |
|
FM Coyle, WM Drake, SL Chew, P Jenkins, RR
Hutchins, AB Grossman, JP Monson & S Bhattacharya |
P526 |
Estrone
and cortisol co-secreting adrenocortical carcinoma in a man presenting
with hypogonadotrophic hypogonadism and painful gynaecomastia |
|
EL Lim, S Razvi, S Vaikkakara, IM Ibrahim,
S Turner, S Johnson, JI Mason, TJW Lennard, R Bliss, S Elloitt,
D Richardson, RD Neely & R Quinton |
P527 |
Origin
and spread of the SDHD p.Y114C mutation causing head and neck paraganglioma
in Trentino, Italy |
|
F Schiavi, Z Erlic, T Savvoukidis, S Demattè,
A Del Piano, ME Cecchini, P Amistà, F Grego, F Trabalzini,
M Hoffman, A Schwentek, F Mantero, F Branz, HPH Neumann & G
Opocher |
P528 |
Characterization
of familial non-syndromic pheochromocytoma |
|
G Opocher, F Schiavi, M Iacobone, S Sattarova,
Z Erlic, M Martella, C Mian, L Zambonin, P De Lazzari, A Murgia,
G Favia & F Mantero |
P529 |
Endostatin
and VEGF levels in serum of patients with pituitary tumors |
|
A Gruszka, J Kunert-Radek, M Pawlikowski,
H Stepien & A Radek |
P530 |
18F-deoxy-D-glucose
positron emission tomography (FDG-PET) increases the detection
rate of recurrent or residual medullary thyroid cancer |
|
A Faggiano, P Ferolla, LC Pezzullo, M Chiofalo,
F Milone, N Mozzillo, G Scarpelli, F Santeusanio, G Angeletti,
G Lombardi & A Colao |
P531 |
Papillary
thyroid microcarcinoma: a low risk neoplasia? |
|
GA Lupoli, S Colarusso, A Panico, F Fonderico,
F Nappi, F Marciello, A Martinelli, P Cuofano, F Lo Calzo, L Vicedomini & G
Lupoli |
P532 |
The
value of fluorine-18 fluorodeoxyglucose PET during follow-up of
patients with medullary thyroid carcinoma |
|
GA Lupoli, S Colarusso, A Panico, F Fonderico,
F Nappi, F Marciello, A Gonnella, MR Poggiano, E Nicolai, M Salvatore & G
Lupoli |
P533 |
N363S
and Bcl I variants in the glucocorticoid receptor gene and their
associations in Cushing's syndrome and Addison's disease |
|
G Arnaldi, G Appolloni, C Polloni, P Romagni,
B Polenta, M Cardinaletti, A Falorni & M Boscaro |
P534 |
Novel
inactivating mutations in four Italian cases of familial hypocalciuric
hypercalcemia |
|
F Cetani, S Borsari, M Lemmi, E Pardi, E
Ambrogini, A Pinchera & C Marcocci |
P535 |
Genetic
analyses of familial isolated primary hyperparathyroidism: implications
for clinical assessment and surgical management |
|
C Marcocci, E Pardi, S Borsari, E Ambrogini,
M Lemmi, A Picone, E Vignali, G Viccica, P Berti, P Miccoli & F
Cetani |
P536 |
Non-pancreatic
carcinoid tumours - prognostic value of proliferative index (Ki67%) |
|
RM Thomas, G Bernstone, S Johnson, D Manas,
RA James & P Perros |
P537 |
Somatostatin
receptor subtypes 1-5 in pituitary tumors of various etiologies:
investigation by immunohistochemistry |
|
N Unger, I Serdiuk, W Saeger, H Wiedemeyer,
J Van de Nes, S Schulz, D Stolke, K Mann & S Petersenn |
P538 |
High
performance liquid chromatography (HPLC) in the follow-up of mitotane
therapy in a patient with adrenal carcinoma |
|
D Thomas, I Kostoglou-Athanassiou, S Bournazos,
N Mytakidis, V Liakos, E Vassiliou, P Athanassiou & PH Kaldrymidis |
P539 |
Multiple
endocrine neoplasia type 1 and angiomyxoma |
|
I Kostoglou-Athanassiou, P Athanassiou, D
Thomas, N Mytakidis, E Vassiliou, V Liakos & PH Kaldrymidis |
P540 |
Novel
L301R heterozygous mutation of the menin gene in a Hungarian MEN
1 family |
|
P Gergics, K Balogh, M Toth, A Patocs, L
Hunyadi, S Czirjak, J Horanyi, A Gyorkos & K Racz |
P541 |
Differences
in the presenting biochemical and imaging data in patients with
acromegaly caused by pure GH adenomas, adenomas with GH and PRL
cell differentiation and plurihormonal adenomas |
|
A Fernandez, N Karavitaki, O Ansorge, V Fazal-Sanderson,
HE Turner & JAH Wass |
P542 |
Management
of thyrotrophin-secreting adenoma with octreotide therapy |
|
AEC Fountain, NM Neary, ECI Hatfield & K
Meeran |
P543 |
Tumor
size and gonadotrophin immunoreactivity of pituitary adenomas |
|
C Badiu, C Stancu, O Filip, D Hortopan, V
Ciubotaru & M Coculescu |
P544 |
Carotid
arterial intima-media thickness (IMT), a marker of atherosclerosis,
does not differ in patients with acromegaly compared to healthy
controls |
|
AN Paisley, JAL Lawrance, R Murray, SM Shalet & PJ
Trainer |
P545 |
Acute
biliary tract problems are common on discontinuation of somatostatin
analogue (SA) therapy |
|
AN Paisley, ME Roberts & PJ Trainer |
P546 |
Cell
proliferation and outcome of GHsecreting pituitary adenomas |
|
L De Marinis, A Bianchi, L Tilaro, F Doglietto,
F Veltri, GV Vellone, F Lugli, A Fusco, V Cimino, A Pontecorvi & L
Lauriola |
P547 |
Efficacy
and safety of high doses of long acting somatostatin analogues
for treatment of well-differentiated functioning neuroendocrine
tumors |
|
P Ferolla, A Faggiano, R Pivonello, G Lombardi,
G Angeletti, A Colao & F Santeusanio |
P548 |
Surgical
debulking of GH secreting adenomas improves control of acromegaly
by lanreotide - a prospective study |
|
JAH Wass, V Fazal-Sanderson, J Byrne, S Rowel,
N Karavitaki, P Trainer & HE Turner |
P549 |
Diagnostic
utility of dexamethazone suppression tests in the work-up of Cushing's
disease |
|
EJ Roderick, K Collison, N Karavitaki, HE
Turner, S Suliman & JAH Wass |
P550 |
Descriptive
epidemiology of thyroid cancer occurring in the population living
in the Rhône Alpes region: 1998-2004 |
|
Z Nejjari, L Remontet, F Borson-Chazot, N
Bossard, N Berger, M Decaussin-Petrucci, J Estève & G
Sassolas |
P551 |
In
vitro effects of SOM230 on primary cultured pheochromocytoma cells |
|
D Pasquali, G Conzo, V Rossi, G Bellastella,
L Maione, A Bellastella & AA Sinisi |
P552 |
Fourier
transform infrared spectroscopy (FTIR) of parathyroid pathology |
|
K Das, N Stone, C Kendall, C Fowler & J
Christie-Brown |
